Intuitive Surgical Research and Development Expenses 2010-2025 | ISRG

Intuitive Surgical annual/quarterly research and development expenses history and growth rate from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Intuitive Surgical research and development expenses for the quarter ending March 31, 2025 were $0.316B, a 11.14% increase year-over-year.
  • Intuitive Surgical research and development expenses for the twelve months ending March 31, 2025 were $1.177B, a 13.35% increase year-over-year.
  • Intuitive Surgical annual research and development expenses for 2024 were $1.145B, a 14.67% increase from 2023.
  • Intuitive Surgical annual research and development expenses for 2023 were $0.999B, a 13.63% increase from 2022.
  • Intuitive Surgical annual research and development expenses for 2022 were $0.879B, a 31% increase from 2021.
Intuitive Surgical Annual Research and Development Expenses
(Millions of US $)
2024 $1,145
2023 $999
2022 $879
2021 $671
2020 $595
2019 $557
2018 $418
2017 $329
2016 $240
2015 $197
2014 $178
2013 $168
2012 $170
2011 $140
2010 $116
2009 $95
Intuitive Surgical Quarterly Research and Development Expenses
(Millions of US $)
2025-03-31 $316
2024-12-31 $295
2024-09-30 $286
2024-06-30 $280
2024-03-31 $285
2023-12-31 $260
2023-09-30 $249
2023-06-30 $244
2023-03-31 $245
2022-12-31 $244
2022-09-30 $217
2022-06-30 $207
2022-03-31 $211
2021-12-31 $183
2021-09-30 $166
2021-06-30 $162
2021-03-31 $160
2020-12-31 $150
2020-09-30 $155
2020-06-30 $143
2020-03-31 $147
2019-12-31 $157
2019-09-30 $136
2019-06-30 $121
2019-03-31 $144
2018-12-31 $120
2018-09-30 $108
2018-06-30 $95
2018-03-31 $96
2017-12-31 $87
2017-09-30 $83
2017-06-30 $85
2017-03-31 $74
2016-12-31 $69
2016-09-30 $63
2016-06-30 $55
2016-03-31 $53
2015-12-31 $53
2015-09-30 $51
2015-06-30 $49
2015-03-31 $44
2014-12-31 $47
2014-09-30 $48
2014-06-30 $40
2014-03-31 $43
2013-12-31 $42
2013-09-30 $43
2013-06-30 $41
2013-03-31 $42
2012-12-31 $42
2012-09-30 $50
2012-06-30 $40
2012-03-31 $38
2011-12-31 $41
2011-09-30 $35
2011-06-30 $32
2011-03-31 $31
2010-12-31 $33
2010-09-30 $27
2010-06-30 $29
2010-03-31 $28
2009-12-31 $26
2009-09-30 $25
2009-06-30 $23
2009-03-31 $21
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $192.166B $8.352B
Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $153.961B 18.62
Alcon (ALC) Switzerland $47.401B 31.51
Edwards Lifesciences (EW) United States $44.018B 28.86
IDEXX Laboratories (IDXX) United States $39.134B 44.97
DexCom (DXCM) United States $32.682B 50.51
IQVIA Holdings (IQV) United States $26.521B 14.85
Mettler-Toledo (MTD) United States $22.538B 26.80
STERIS (STE) Ireland $22.108B 25.28
Waters (WAT) United States $20.558B 29.01
SONOVA HOLDING (SONVY) Switzerland $18.317B 0.00
Hologic (HOLX) United States $12.352B 13.42
Sysmex ADR (SSMXY) Japan $11.507B 0.00
Penumbra (PEN) United States $11.201B 87.92
Globus Medical (GMED) United States $9.836B 22.77
Masimo (MASI) United States $8.139B 30.02
Teleflex (TFX) United States $5.395B 8.90
Glaukos (GKOS) United States $5.042B 0.00
Integer Holdings (ITGR) United States $4.151B 21.75
TransMedics (TMDX) United States $3.241B 94.86
PROCEPT BioRobotics (PRCT) United States $2.939B 0.00
Veracyte (VCYT) United States $2.415B 33.89
LivaNova (LIVN) United Kingdom $2.372B 14.12
Nihon Kohden (NHNKY) Japan $2.127B 11.63
Elekta AB (EKTAY) Sweden $1.860B 16.72
Alphatec Holdings (ATEC) United States $1.820B 0.00
Tandem Diabetes Care (TNDM) United States $1.483B 0.00
Artivion (AORT) United States $1.212B 113.52
Pulse Biosciences (PLSE) United States $1.123B 0.00
OPKO Health (OPK) United States $0.991B 0.00
Integra LifeSciences Holdings (IART) United States $0.989B 5.26
AxoGen (AXGN) United States $0.746B 0.00
SiBone (SIBN) United States $0.744B 0.00
Mesa Laboratories (MLAB) United States $0.654B 14.29
IRadimed (IRMD) United States $0.649B 32.91
Beta Bionics (BBNX) United States $0.623B 0.00
RxSight (RXST) United States $0.605B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.582B 9.05
OrthoPediatrics (KIDS) United States $0.539B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.469B 0.00
Treace Medical Concepts (TMCI) United States $0.453B 0.00
NeuroPace (NPCE) United States $0.397B 0.00
Delcath Systems (DCTH) United States $0.388B 0.00
ClearPoint Neuro (CLPT) United States $0.372B 0.00
AngioDynamics (ANGO) United States $0.356B 0.00
Pacific Biosciences Of California (PACB) United States $0.339B 0.00
Semler Scientific (SMLR) United States $0.317B 6.73
Neuronetics (STIM) United States $0.300B 0.00
Tactile Systems Technology (TCMD) United States $0.224B 13.58
CVRx (CVRX) United States $0.195B 0.00
908 Devices (MASS) United States $0.194B 0.00
Inogen (INGN) United States $0.193B 0.00
Alpha Tau Medical (DRTS) Israel $0.191B 0.00
Spectral Diagnostics (EDTXF) Canada $0.174B 0.00
LENSAR (LNSR) United States $0.163B 0.00
Sight Sciences (SGHT) United States $0.148B 0.00
Anteris Technologies Global (AVR) Australia $0.145B 0.00
Accuray (ARAY) United States $0.140B 0.00
KORU Medical Systems (KRMD) United States $0.126B 0.00
Lucid Diagnostics (LUCD) United States $0.125B 0.00
Atossa Genetics (ATOS) United States $0.105B 0.00
Rapid Micro Biosystems (RPID) United States $0.100B 0.00
Monogram Orthopaedics (MGRM) United States $0.094B 0.00
Microbot Medical (MBOT) United States $0.087B 0.00
EDAP TMS S.A (EDAP) France $0.085B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
Sensus Healthcare (SRTS) United States $0.070B 10.55
EnVVeno Medical (NVNO) United States $0.066B 0.00
Zomedica (ZOMDF) United States $0.056B 0.00
Hyperfine (HYPR) United States $0.055B 0.00
Covalon Technologies (CVALF) Canada $0.050B 15.29
Vicarious Surgical (RBOT) United States $0.049B 0.00
Biosig Technologies (BSGM) United States $0.036B 0.00
Baird Medical Investment Holdings (BDMD) $0.035B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.029B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.020B 0.00
NexGel (NXGL) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.013B 0.00
PAVmed (PAVM) United States $0.013B 0.00
Accelerate Diagnostics (AXDX) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
WORK Medical Technology Group (WOK) China $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.14
Longview Acquisition II (LGV) United States $0.000B 0.00